LOS ANGELES, April 2, 2014 /PRNewswire/ -- Verde Media
Group Inc. (OTC: VMGI) Verde Media Group Inc. is pleased to
announce that it is has entered into the medical and cosmetics
industry through its newly created subsidiary Beautyject Inc.
Beautyject is in final negotiations to in-license a unique
proprietary needleless technology redefining known delivery
methods.
Beautyject is in advanced discussions with a major group for the
sale and distribution of its needleless delivery system throughout
North America. Upon completion of
this agreement management expects revenues from the sale of this
system will generate upwards of $25M
in its first year of commercialization.
The technology allows individuals to inject various solutions
that reduce and remove skin wrinkles without the use of any needles
as one of the many uses that will be employed with the Beautyject
system. The injectors have a long shelf life and are virtually
painless avoiding blood vessel and nerve damage associated with
repetitive needle injections. The Verde Media Biotech Division
(VMBD) further plans to extend the application to $240B anti-aging industry including painless
injections of growth hormone and collagens that often require daily
injections.
William Veve, President of Verde
Media Group, Inc. stated, "The addition of Beautyject to the Verde
family is a significant milestone for our company as we advance our
business plan for rapid growth."
About Verde Media Group Inc.
Verde Media Group Inc. is a publicly traded company listed on
the OTC Markets trading under the stock symbol: VMGI. Verde
Media Group Inc. The Company consists of three divisions:
Agency Division- The innovative Agency division services-
public relations, marketing, sales and transaction functions for
corporate clientele. The agency is rapidly expanding its
business in the Denver, Colorado
market that will become the largest legal retail marijuana
sector.
BioTech Division- The VMBD division undertakes the business of
developing and producing high value bio-products from renewable
biomass. The focus and criterion is to develop proprietary
microbial technologies with low risk scale-up methods employing low
cost feedstock. VMBD will further develop the derivative and
ester forms of THC for increase in potency and their use in
different delivery systems, including sublingual, inhaled dosage
forms and blending with food products.
Entertainment Division- The Company operates a managed
media company with production, distribution, development, and
acquisition functions for film and television.
For more information, visit www.verdemediagroup.com, or connect
with the company on Facebook. Twitter- @Verdemediagroup
DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING
STATEMENTS
The results described herein cannot be guaranteed. This release
contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Statements in this news release other than statements of historical
fact are "forward-looking statements" that are based on current
expectations and assumptions.
Logo -
http://photos.prnewswire.com/prnh/20140219/PH68218LOGO
SOURCE Verde Media Group Inc.
